1 / 22

Estimating bioavailability

denis
Télécharger la présentation

Estimating bioavailability

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. BIOAVAILABILITYTime course of drug in the body: route of drug administrationOral vs IV injectionReasons for differences: completeness and rate of absorptionDefinition: rate and extent to which a drug substance or its active moiety is delivered from the dosage form to the systemic circulation

  2. Estimating bioavailability • Absolute bioavailability, AUC estimates from extravascular and IV administration • Relative bioavailability Characteristics to be investigated: • Shape and area of the plasma concentration vs time curve • AUCt, AUCinfinity, Cmax, Tmax Estimating the rate of absorption • Important for drugs that need prompt therapeutic effect • Cmax and Tmax

  3. Physiologic Factors Related to Drug Absorption The systemic absorption of drugs is dependent on • Physicochemical properties of the drug • Nature of drug product • Anatomy and physiology of the absorption site

  4. Nature of cell membranes • Important barrier to drug delivery • Major structure of cells • Enclose cellular content and organelles • Semipermeable partitions, selective barriers • Thin, 70-100 A • Composed primarily of phospholipids, carbohydrates and proteins

  5. Theories of cell membrane structure • The Lipid Bilayer or Unit Membrane Theory (1952): considers the membrane as lipid bilayer with proteins on the surface !! explains transport of lipophilic substances, but not hydrophilic ones • Fluid Mosaic Theory (1972) • Lipid membrane structure in relation to drug research Stratified layer composed of Layer 1: perturbed water layer Layer 2: hydrophilic/hydrophobic layer including bound water, lipid polar head groups and parts of the upper acyl chains Layer 3: conformationally ordered acyl chain segments Layer 4: conformationally disordered acyl chain segments

  6. Membrane asymmetry Movement of lipids in the bilayer is either • Flip flop or transverse diffusion and this is not common • Rotation of the phospholipids about their long axis: very common • Lateral diffusion in the plane of the membrane

  7. The effect of sterols on membrane fluidity Membrane proteins • Integral membrane proteins • Peripheral membrane proteins • Lipid anchored membrane proteins Membrane protein asymmetry Lipid protein interactions: hydrophobic matching, lipid sorting and lipid selectivity

  8. Transport of drugs across cell membranes I Simple or passive diffusion • Spont. high conc. to low conc. • Passive: no energy consumption • Basis: lipid solubility, conc. gradient • Rate of transport = flux, vector • Major absorption process for drugs

  9. Controlled by Fick’s Law of diffusion dQ = DAK (CGI-Cplasma) dt h dQ/dt = rate of diffusion D = diffusion coefficient A = surface area available for diffusion K = lipid-water partition coefficient h = membrane thickness C1 and C2 are the conc. at both sides of the membrane

  10. Factors influencing passive diffusion • D: constant for each drug molecule (cm2/sec) • h: constant for a particular absorption site • K: hydrophobic vs. hydrophilic • A: surface area available for transport

  11. Assuming that: 1. D, A, K, and h are constants for a specific membrane, specific drug, the Permeability coefficient (P) could be defined P = DAK h  2. C1>>>>>>>C2  dQ/dt = P (C1) (1st order kinetics)

  12. II Carrier mediated transport Specialized carrier mediated transport systems Active transport • Carrier mediated, transmembrane, energy requiring • Against conc. gradient • GI absorption, renal and biliary secretion • 5 fluorouracil • High selectivity • Saturable

  13. Facilitated diffusion, facilitated transport • Carrier mediated, transmembrane, • No energy, downhill • Minor role in drug absorption • Saturable

  14. Carrier mediated vs. Passive diffusion 1. No. of carriers • Rate of transport (Michaelis-Menten) • Rate of absorption = Vmax C Km + C • C= solute conc. at the absorption site • Vmax and Km = constants • at low conc. Km>>>>>>>>>>C • Rate of absorption = Vmax C Km (1st order kinetics)

  15. at higher conc. C>>>>>>>>>>>Km • Rate of absorption = Vmax • Difference in the plots rate of transport vs. drug concentration at absorption site • Selectivity and specificity • Competition • Inhibition: cellular metabolism

  16. III Paracellular • Across tight junctions between the cells • Molecular size limitation VI Vesicular transport • A vesicle: small spherical membranous sac formed by budding off from an existing membrane • Endocytosis and Exocytosis • Endocytosis • Material is brought into the cell • Phagocytosis: particles Phagocytes, macrophages  • Pinocytosis: nonselective uptake of droplets

  17. Receptor mediated endocytosis: highly selective endocytosis Transferrin, vitamins, hormones, LDL, antibodies  Binding Vesicle formation: clathrin coated vesicle Uncoating Fusion with an early endosome Recycling Degradation Transcytosis

  18. Potocytosis: caveolae • VII P-glycoprotein (permeability glycoprotein) ATP dependent efflux pump

More Related